Immunotherapeutic Drugs Market, Global Outlook and Forecast 2023-2028

Report ID: 1371553 | Published Date: Jan 2025 | No. of Page: 69 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Immunotherapeutic Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Immunotherapeutic Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Immunotherapeutic Drugs Overall Market Size
    2.1 Global Immunotherapeutic Drugs Market Size: 2021 VS 2028
    2.2 Global Immunotherapeutic Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Immunotherapeutic Drugs Players in Global Market
    3.2 Top Global Immunotherapeutic Drugs Companies Ranked by Revenue
    3.3 Global Immunotherapeutic Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Immunotherapeutic Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Immunotherapeutic Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Immunotherapeutic Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Immunotherapeutic Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Immunotherapeutic Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Immunotherapeutic Drugs Market Size Markets, 2021 & 2028
        4.1.2 Monoclonal Antibody
        4.1.3 Vaccines
        4.1.4 Checkpoint Inhibitor
        4.1.5 Interferon
    4.2 By Type - Global Immunotherapeutic Drugs Revenue & Forecasts
        4.2.1 By Type - Global Immunotherapeutic Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Immunotherapeutic Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Immunotherapeutic Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Immunotherapeutic Drugs Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Other
    5.2 By Application - Global Immunotherapeutic Drugs Revenue & Forecasts
        5.2.1 By Application - Global Immunotherapeutic Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Immunotherapeutic Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Immunotherapeutic Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Immunotherapeutic Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Immunotherapeutic Drugs Revenue & Forecasts
        6.2.1 By Region - Global Immunotherapeutic Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Immunotherapeutic Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Immunotherapeutic Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Immunotherapeutic Drugs Revenue, 2017-2028
        6.3.2 US Immunotherapeutic Drugs Market Size, 2017-2028
        6.3.3 Canada Immunotherapeutic Drugs Market Size, 2017-2028
        6.3.4 Mexico Immunotherapeutic Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Immunotherapeutic Drugs Revenue, 2017-2028
        6.4.2 Germany Immunotherapeutic Drugs Market Size, 2017-2028
        6.4.3 France Immunotherapeutic Drugs Market Size, 2017-2028
        6.4.4 U.K. Immunotherapeutic Drugs Market Size, 2017-2028
        6.4.5 Italy Immunotherapeutic Drugs Market Size, 2017-2028
        6.4.6 Russia Immunotherapeutic Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Immunotherapeutic Drugs Market Size, 2017-2028
        6.4.8 Benelux Immunotherapeutic Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Immunotherapeutic Drugs Revenue, 2017-2028
        6.5.2 China Immunotherapeutic Drugs Market Size, 2017-2028
        6.5.3 Japan Immunotherapeutic Drugs Market Size, 2017-2028
        6.5.4 South Korea Immunotherapeutic Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Immunotherapeutic Drugs Market Size, 2017-2028
        6.5.6 India Immunotherapeutic Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Immunotherapeutic Drugs Revenue, 2017-2028
        6.6.2 Brazil Immunotherapeutic Drugs Market Size, 2017-2028
        6.6.3 Argentina Immunotherapeutic Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Immunotherapeutic Drugs Revenue, 2017-2028
        6.7.2 Turkey Immunotherapeutic Drugs Market Size, 2017-2028
        6.7.3 Israel Immunotherapeutic Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Immunotherapeutic Drugs Market Size, 2017-2028
        6.7.5 UAE Immunotherapeutic Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Roche
        7.1.1 Roche Corporate Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche Immunotherapeutic Drugs Major Product Offerings
        7.1.4 Roche Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.1.5 Roche Key News
    7.2 Merck
        7.2.1 Merck Corporate Summary
        7.2.2 Merck Business Overview
        7.2.3 Merck Immunotherapeutic Drugs Major Product Offerings
        7.2.4 Merck Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.2.5 Merck Key News
    7.3 Novartis
        7.3.1 Novartis Corporate Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Immunotherapeutic Drugs Major Product Offerings
        7.3.4 Novartis Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.3.5 Novartis Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Immunotherapeutic Drugs Major Product Offerings
        7.4.4 Johnson & Johnson Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.4.5 Johnson & Johnson Key News
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Corporate Summary
        7.5.2 GlaxoSmithKline Business Overview
        7.5.3 GlaxoSmithKline Immunotherapeutic Drugs Major Product Offerings
        7.5.4 GlaxoSmithKline Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.5.5 GlaxoSmithKline Key News
    7.6 AbbVie
        7.6.1 AbbVie Corporate Summary
        7.6.2 AbbVie Business Overview
        7.6.3 AbbVie Immunotherapeutic Drugs Major Product Offerings
        7.6.4 AbbVie Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.6.5 AbbVie Key News
    7.7 ELI Lilly
        7.7.1 ELI Lilly Corporate Summary
        7.7.2 ELI Lilly Business Overview
        7.7.3 ELI Lilly Immunotherapeutic Drugs Major Product Offerings
        7.7.4 ELI Lilly Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.7.5 ELI Lilly Key News
    7.8 Amgen
        7.8.1 Amgen Corporate Summary
        7.8.2 Amgen Business Overview
        7.8.3 Amgen Immunotherapeutic Drugs Major Product Offerings
        7.8.4 Amgen Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.8.5 Amgen Key News
    7.9 AstraZeneca
        7.9.1 AstraZeneca Corporate Summary
        7.9.2 AstraZeneca Business Overview
        7.9.3 AstraZeneca Immunotherapeutic Drugs Major Product Offerings
        7.9.4 AstraZeneca Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.9.5 AstraZeneca Key News
    7.10 Bristol-Mysers Squibb
        7.10.1 Bristol-Mysers Squibb Corporate Summary
        7.10.2 Bristol-Mysers Squibb Business Overview
        7.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Major Product Offerings
        7.10.4 Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue in Global Market (2017-2022)
        7.10.5 Bristol-Mysers Squibb Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Immunotherapeutic Drugs Market Opportunities & Trends in Global Market
    Table 2. Immunotherapeutic Drugs Market Drivers in Global Market
    Table 3. Immunotherapeutic Drugs Market Restraints in Global Market
    Table 4. Key Players of Immunotherapeutic Drugs in Global Market
    Table 5. Top Immunotherapeutic Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Immunotherapeutic Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Immunotherapeutic Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Immunotherapeutic Drugs Product Type
    Table 9. List of Global Tier 1 Immunotherapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Immunotherapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Immunotherapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Immunotherapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Immunotherapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Immunotherapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Immunotherapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Immunotherapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Immunotherapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Immunotherapeutic Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Immunotherapeutic Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Immunotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Immunotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Immunotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Immunotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Immunotherapeutic Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Roche Corporate Summary
    Table 31. Roche Immunotherapeutic Drugs Product Offerings
    Table 32. Roche Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Merck Corporate Summary
    Table 34. Merck Immunotherapeutic Drugs Product Offerings
    Table 35. Merck Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Novartis Corporate Summary
    Table 37. Novartis Immunotherapeutic Drugs Product Offerings
    Table 38. Novartis Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Johnson & Johnson Corporate Summary
    Table 40. Johnson & Johnson Immunotherapeutic Drugs Product Offerings
    Table 41. Johnson & Johnson Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. GlaxoSmithKline Corporate Summary
    Table 43. GlaxoSmithKline Immunotherapeutic Drugs Product Offerings
    Table 44. GlaxoSmithKline Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. AbbVie Corporate Summary
    Table 46. AbbVie Immunotherapeutic Drugs Product Offerings
    Table 47. AbbVie Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. ELI Lilly Corporate Summary
    Table 49. ELI Lilly Immunotherapeutic Drugs Product Offerings
    Table 50. ELI Lilly Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Amgen Corporate Summary
    Table 52. Amgen Immunotherapeutic Drugs Product Offerings
    Table 53. Amgen Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. AstraZeneca Corporate Summary
    Table 55. AstraZeneca Immunotherapeutic Drugs Product Offerings
    Table 56. AstraZeneca Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Bristol-Mysers Squibb Corporate Summary
    Table 58. Bristol-Mysers Squibb Immunotherapeutic Drugs Product Offerings
    Table 59. Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Immunotherapeutic Drugs Segment by Type in 2021
    Figure 2. Immunotherapeutic Drugs Segment by Application in 2021
    Figure 3. Global Immunotherapeutic Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Immunotherapeutic Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Immunotherapeutic Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Immunotherapeutic Drugs Revenue in 2021
    Figure 8. By Type - Global Immunotherapeutic Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Immunotherapeutic Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Immunotherapeutic Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Immunotherapeutic Drugs Revenue Market Share, 2017-2028
    Figure 12. US Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Immunotherapeutic Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Immunotherapeutic Drugs Revenue Market Share, 2017-2028
    Figure 24. China Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Immunotherapeutic Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Immunotherapeutic Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Immunotherapeutic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Roche Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Merck Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novartis Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Johnson & Johnson Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. GlaxoSmithKline Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AbbVie Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. ELI Lilly Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Amgen Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. AstraZeneca Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
69
Frequently Asked Questions
Immunotherapeutic Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immunotherapeutic Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immunotherapeutic Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports